Search Results - "Piccari, Lucilla"

Pulmonary vasculature in COPD: The silent component by Blanco, Isabel, Piccari, Lucilla, Barberà, Joan Albert

“…Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction that results from an inflammatory process affecting the airways and lung…”
Get full text

Derivation and characterisation of endothelial cells from patients with chronic thromboembolic pulmonary hypertension by Tura-Ceide, Olga, Smolders, Valérie F. E. D., Aventin, Núria, Morén, Constanza, Guitart-Mampel, Mariona, Blanco, Isabel, Piccari, Lucilla, Osorio, Jeisson, Rodríguez, Cristina, Rigol, Montserrat, Solanes, Núria, Malandrino, Andrea, Kurakula, Kondababu, Goumans, Marie Jose, Quax, Paul H. A., Peinado, Victor I., Castellà, Manuel, Barberà, Joan Albert

“…Pulmonary endarterectomy (PEA) resected material offers a unique opportunity to develop an in vitro endothelial cell model of chronic thromboembolic pulmonary…”
Get full text

Pulmonary vascular disease, environmental pollution, and climate change by Lichtblau, Mona, Reimann, Lena, Piccari, Lucilla

“…Pollution and climate change constitute a combined, grave and pervasive threat to humans and to the life‐support systems on which they depend. Evidence shows a…”
Get full text

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension by Piccari, Lucilla, Allwood, Brian, Antoniou, Katerina, Chung, Jonathan H, Hassoun, Paul M, Nikkho, Sylvia M, Saggar, Rajan, Shlobin, Oksana A, Vitulo, Patrizio, Nathan, Steven D, Wort, Stephen John

“…Pulmonary hypertension (PH) is a frequent complication of interstitial lung disease (ILD). Although PH has mostly been described in idiopathic pulmonary…”
Get full text

Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension by Nikkho, Sylvia M., Richter, Manuel J., Shen, Eric, Abman, Steven H., Antoniou, Katerina, Chung, Jonathan, Fernandes, Peter, Hassoun, Paul, Lazarus, Howard M., Olschewski, Horst, Piccari, Lucilla, Psotka, Mitchell, Saggar, Rajan, Shlobin, Oksana A., Stockbridge, Norman, Vitulo, Patrizio, Vizza, Carmine Dario, Wort, Stephen J., Nathan, Steven D.

“…Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases. The presence of PH in the setting of underlying Interstitial Lung…”
Get full text

Effect of targeted therapy on circulating progenitor cells in precapillary pulmonary hypertension by García-Lucio, Jéssica, BsC, Tura-Ceide, Olga, PhD, del Pozo, Roberto, MD, Blanco, Isabel, MD, Pizarro, Sandra, MD, Ferrer, Elisabet, PhD, Díez, Marta, PhD, Coll-Bonfill, Núria, BsC, Piccari, Lucilla, MD, Peinado, Víctor I., PhD, Barberà, Joan Albert, MD

“…Abstract Background Endothelial dysfunction is key in the development of pulmonary hypertension (PH) and is associated with reduced number of circulating…”
Get full text

Association Between Systemic and Pulmonary Vascular Dysfunction in COPD by Piccari, Lucilla, Del Pozo, Roberto, Blanco, Isabel, Garcfa-Lucio, Jessica, Torralba, Yolanda, Tura-Ceide, Olga, Moises, Jorge, Sitges, Marta, Peinado, Victor Ivo, Barbera, Joan Albert

“…Introduction: In chronic obstructive pulmonary disease (COPD), endothelial dysfunction and stiffness of systemic arteries may contribute to increased…”
Get full text

The European Voice of the Patient living with pulmonary hypertension associated with interstitial lung disease: Diagnosis, symptoms, impacts, and treatments by Piccari, Lucilla, Kovacs, Gabor, Jones, Steve, Skaara, Hall, Herms, Claudia Roca, Jeanneret, Gabriela Silvina Bacchini, Vinardell, Melquiades Calzado, Guix, Nuria Gonzalez‐Rojas, Delgado, Miriam Fernandez, García, Héctor Gálvez, Schwicker, David

“…Pulmonary hypertension (PH) adds a substantial disease burden, including higher mortality, when associated with interstitial lung disease (ILD), a severe,…”
Get full text

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension by Shlobin, Oksana A., Shen, Eric, Wort, Stephen J., Piccari, Lucilla, Scandurra, John A., Hassoun, Paul M., Nikkho, Sylvia M., Nathan, Steven D.

“…Pulmonary hypertension (PH) due to interstitial lung disease (ILD), a commonly encountered complication of fibrotic ILDs, is associated with significant…”
Get full text

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture? by Piccari, Lucilla, Bernardo, Roberto J., Rodríguez-Chiaradía, Diego, Vitulo, Patrizio, Wort, S. John, Sahay, Sandeep

Get full text

Iron Replacement and Redox Balance in Non-Anemic and Mildly Anemic Iron Deficiency COPD Patients: Insights from a Clinical Trial by Pérez-Peiró, Maria, Martín-Ontiyuelo, Clara, Rodó-Pi, Anna, Piccari, Lucilla, Admetlló, Mireia, Durán, Xavier, Rodríguez-Chiaradía, Diego A, Barreiro, Esther

“…In COPD patients, non-anemic iron deficiency (NAID) is a common systemic manifestation. We hypothesized that in COPD patients with NAID, iron therapy may…”
Get full text

Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension by Nathan, Steven D., Fernandes, Peter, Psotka, Mitchell, Vitulo, Patrizio, Piccari, Lucilla, Antoniou, Katerina, Nikkho, Sylvia M., Stockbridge, Norman

“…Pulmonary hypertension (PH) associated with interstitial lung disease (ILD) is an attractive target for clinical trials of PH medications. There are many…”
Get full text

ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly by Cullivan, Sarah, Boucly, Athénaïs, Jevnikar, Mitja, Lechartier, Benoit, Ulrich, Silvia, Bertoletti, Laurent, Sitbon, Olivier, Vonk-Noordegraaf, Anton, Bokan, Aleksandar, Park, Da-Hee, Genecand, Leon, Guiot, Julien, Jutant, Etienne-Marie, Piccari, Lucilla, Lichtblau, Mona

“…Pulmonary vascular diseases such as pulmonary embolism and pulmonary hypertension are important and frequently under-recognised conditions. This article…”
Get full text

Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension by Rodríguez-Chiaradía, Diego A, Khilzi, Karys, Blanco, Isabel, Rodó-Pin, Anna, Martin-Ontiyuelo, Clara, Herranz Blasco, Anna, Garcia-Lucio, Jessica, Molina, Lluis, Marco, Ester, Barreiro, Esther, Piccari, Lucilla, Peinado, Victor I, Garcia, Agustín R, Tura-Ceide, Olga, Barberà, Joan Albert

“…In stable patients with pulmonary arterial hypertension (PAH), pulmonary rehabilitation (PR) is an effective, safe and cost-effective non-pharmacological…”
Get full text

ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly by Lichtblau, Mona, Piccari, Lucilla, Ramjug, Sheila, Bokan, Aleksandar, Lechartier, Benoit, Jutant, Etienne-Marie, Barata, Margarida, Garcia, Agustin Roberto, Howard, Luke S, Adir, Yochai, Delcroix, Marion, Jara-Palomares, Luis, Bertoletti, Laurent, Sitbon, Olivier, Ulrich, Silvia, Vonk Noordegraaf, Anton

“…This article aims to summarise the latest research presented at the virtual 2021 European Respiratory Society (ERS) International Congress in the field of…”
Get full text

Emerging phenotypes of pulmonary hypertension associated with COPD a field guide by García, Agustín Roberto, Piccari, Lucilla

Get full text

Fossil Industry and Respiratory Societies: Time for a Clear Stand by Piccari, Lucilla, Kaminski, Naftali, Mann, Michael E

Get full text

Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide by García, Agustín Roberto, Piccari, Lucilla

“…Pulmonary hypertension (PH) is a common complication of chronic obstructive lung disease (COPD), but clinical presentation is variable and not always…”
Get full text

Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities? by Piccari, Lucilla, Aguilar-Colindres, Ricardo, Rodríguez-Chiaradía, Diego A.

“…Pulmonary hypertension (PH) is a common complication of both chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD), classified as…”
Get full text

Mechanisms of hypoxaemia in severe pulmonary hypertension associated with COPD by Piccari, Lucilla, Blanco, Isabel, Torralba, Yolanda, Arismendi, Ebymar, Gistau, Concepción, Ramírez, Ana, Gimeno-Santos, Elena, Roca, Josep, Burgos, Felip, Rodríguez-Roisín, Roberto, Barberà, Joan Albert

Get more information